Watch for Tirzepatide for Sleep Apnea

September 2026

Tirzepatide (Zepbound) will be the first med approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity.

We’re used to dispensing this GIP/GLP-1 agonist to treat obesity.

Now injectable tirzepatide is also approved for adults with obesity AND obstructive sleep apnea...or blockage of the airway while sleeping.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Immunizations Know What's New With Flu Vaccines for 2026-2027
Sleep Disorders Watch for Tirzepatide for Sleep Apnea
COVID-19 Expect Common Questions About COVID-19 Vaccines
Gastroenterology Know the Latest on Treating Anal Fissures
Pediatrics When Kids Have Type 2 Diabetes: A Treatment Guide
Med Safety Help Prevent Mishaps Involving Unusual Dosing Schedules
Supplements Help Patients Navigate the Peptide Craze
NatMed Spotlight Be Ready to Answer Questions About “Fibremaxxing”